Specialists for T-cell/histiocyte rich large B cell lymphoma

12 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Mengyang Di, MD, PhD, MD
Rare Disease / Clinical Research
Fred Hutch/University of Washington Cancer Consortium
SEATTLE, WA
PI×2
Stephen M Ansell, M.D
Rare Disease / Clinical Research
Dana-Farber - Harvard Cancer Center LAO
ROCHESTER, MN
PI×1 5
Jennifer Crombie, MD, M.D
Rare Disease / Clinical Research
Dana-Farber Cancer Institute
BOSTON, MA
PI×3
David A Bond, MD
Rare Disease / Clinical Research
Ohio State University Comprehensive Cancer Center
PI×2
Reem Karmali, MD, MD
Rare Disease / Clinical Research
Northwestern University
CHICAGO, IL
PI×6
Claire Tiger, MD, PhD, M.D
Rare Disease / Clinical Research
Mayo Clinic
ROCHESTER, MN
PI×1NORD CoE
Ryan Lynch
Rare Disease / Clinical Research
Fred Hutch/University of Washington Cancer Consortium
PI×4 8
Frank G Basile, M.D., MD
Rare Disease / Clinical Research
Schrodinger Inc.
RIVERSIDE, RI
PI×1
Mark J Roschewski, M.D., MD
Rare Disease / Clinical Research
National Cancer Institute (NCI)
WASHINGTON, DC
PI×8
Christopher J Melani, M.D
Rare Disease / Clinical Research
ECOG-ACRIN Cancer Research Group
BALTIMORE, MD
PI×1 1
Connor Johnson, MD
Rare Disease / Clinical Research
Massachusetts General Hospital
PI×1
Chet Bohac, PharmD, MD, MSc
Rare Disease / Clinical Research
Executive Medical Director, Clinical Development, Xencor, Inc.
PI×1

More about T-cell/histiocyte rich large B cell lymphoma